(MENAFN- EIN Presswire) EINPresswire/ -- The Peptide Microarray Market is valued at USD 903.8 million in 2025 and is projected to reach USD 1,316.4 million by 2035, expanding at a 3.8% CAGR. Growth is ...
Seasoned global pharmaceutical executive, Mr Brent MacGregor, joins Vaxxas Board to accelerate self-administered HD-MAP vaccines for global ...
9hon MSN
Stick–slip nanopore approach streamlines protein analysis by using electrical 'fingerprints'
A technology developed in the laboratory of Prof. Amit Meller from the Technion—Israel Institute of Technology Faculty of ...
Pitt BioForge Announces Successful Completion of Advanced Manufacturing of Microarray Patches with Panther Life Sciences ...
WASHINGTON (AP) — Unapproved peptide drugs have become a trendy new hack among wellness influencers, fitness coaches and ...
Precipitation-based purification method could replace current Protein A–reliant methods, significantly reducing manufacturing costs of mAbs.
Studying T cells, the immune cells most responsible for responding to infections and cancers, just received a significant ...
The global biochips market, valued at US$12.97 billion in 2024, stood at US$14.01 billion in 2025 and is projected to advance ...
Explore how Amperia™ combines speed, accuracy, and ease of use to streamline protein quantification and accelerate biologic ...
Advances in molecular diagnostics have driven multiplex biomarker detection as a critical approach for enhanced diagnostic ...
In this eBook, we focus on both considerations for resins, a major operating cost for a vast majority of protein therapeutics, and filtration through a series of articles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback